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Introduction
In order to assess long-term safety of radioactive iodine
administration in treatment of thyrotoxicosis, we
assessed concentrations of selected markers of risk
cardiovascular disease, i.e. matrix metalloproteinase
2 (MMP-2), its main inhibitor TIMP-2, matrix metallo-
proteinase 9 (MMP-9), its main inhibitor TIMP-1, as
well concentrations of anti-inflammatory adiponectin
and pro-inflammatory thrombospondin.
Material and methods
The study involved 23 patients (3 males) age 53±12 (mean
±SD) years treated with radioiodine for thyrotoxicosis.
Serum concentrations TSH, fT4, fT3, MMP-2, MMP-9,
TIMP-1, TIMP-2, adiponectin and thrombospondin were
measured just before radioiodine administration (visit 1),
and subsequently, after 7 days (visit 2), 3 months (visit 3),
six to eight months (visit 4) and 15-18 months after radio-
iodine administration (visit 5).
Results
There were no acute changes in serum concentrations
of MMP-2, MMP-9, TIMP-1 and TIMP-2 adiponectin
and thrombospondin (visit 1 versus visit 2). Subse-
quently, however, there was no change in serum MMP-
9 or thrombospondin, but an increase in MMP-2 (from
393±106 ng/ml, to 774 ± 424 ng/ml), TIMP-1 (from
177 ± 76 ng/ml to 296 ± 118 ng/ml), TIMP-2 (from 136
± 44 ng/ml to 168 ± 41 ng/ml), and adiponectin (from
16442±9490 ng/ml to 23518 ± 9840 ng/ml), visit 1 to
visit 5 respectively, p<0.01). Further analysis, however,
revealed no significant change in MMP-2/TIMP-2 ratio,
but there was a significant decrease in MMP-9/TIMP-1
ratio (p<0.05), suggestive of possible decrease in concen-
trations of free MMP-9.
Conclusions
Our data reveal a significant and sustained increase in
serum adiponectin as well as possible decrease of con-
centration of free MMP-9 after radioiodine administra-
tion. This might indicate overall safety of radioiodine
treatment of thyrotoxicosis in terms of the risks of car-
diovascular disease.
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